血小板凝集裝置市場規模、佔有率及成長分析（按產品、應用、最終用戶和地區分類）－產業預測（2026-2033）

全球血小板凝集裝置市場規模預計在 2024 年達到 5.9051 億美元，從 2025 年的 6.3066 億美元成長到 2033 年的 10.675 億美元，在預測期（2026-2033 年）內複合年成長率為 6.8%。

全球血小板凝集分析儀市場正經歷顯著成長，這主要得益於多種促進因素​​。目標疾病盛行率的上升和老年人口的不斷成長是推動這一成長趨勢的重要因素。血小板凝集測量技術的創新，對於分析血小板功能及相關疾病至關重要，也是推動市場動態。此外，產業領導者與學術機構之間合作的加強，以及臨床研究的蓬勃發展，都在推動市場創新。然而，市場仍面臨許多挑戰，例如臨床操作流程的限制、美國醫療保健體系的改革以及訓練有素的專業人員短缺等，這些都可能阻礙市場的潛在發展。總而言之，該市場呈現出充滿活力的格局，既蘊藏著機遇，也面臨挑戰。

全球血小板凝集裝置市場促進因素

全球對血小板凝集分析儀的需求不斷成長，為該市場的相關人員帶來了巨大的發展機會。推動這項需求激增的主要因素是全球慢性病和出血性疾病盛行率的上升。隨著這些疾病的日益普遍，對先進診斷和監測工具的需求也隨之增加。血小板凝集分析儀在此背景下至關重要，因為它們能夠評估血小板功能，並且對於診斷和治療各種凝血相關疾病必不可少。預計其在醫療保健領域的重要性將在不久的將來推動市場擴張。

限制全球血小板凝集裝置市場的因素

全球血小板凝集儀市場面臨著阻礙其擴張的許多挑戰。其中一個主要障礙是這些設備的高成本，這給醫療機構和設施帶來了沉重的經濟負擔，往往限制了它們投資此類先進診斷技術的能力。此外，缺乏訓練有素的操作和維護人員也加劇了這個問題，導致設備利用率低下，效率低。高成本和缺乏專業技術人員的雙重限制阻礙了市場的成長潛力，並最終限制了患者和醫療服務提供者獲得必要的診斷能力。

全球血小板凝集裝置市場趨勢

由於全球範圍內止血功能障礙的發生率不斷上升，血小板凝集設備市場正經歷強勁成長。影響血液凝固過程的疾病發生率不斷攀升，導致對有效診斷工具的需求日益成長，尤其是那些能夠評估血小板功能和識別凝血障礙的工具。隨著醫療專業人員認知到血小板凝集檢測在疾病管理中的重要性，對創新可靠設備的需求也隨之飆升。技術進步以及臨床醫生對準確止血評估益處的認知不斷提高，也推動了這一趨勢，預計這將在未來幾年持續促進市場擴張。

目錄

介紹

• 調查目標
• 調查範圍
• 定義

調查方法

• 資訊收集
• 二手資料和一手資料方法
• 市場規模預測
• 市場假設與限制

執行摘要

• 全球市場展望
• 供需趨勢分析
• 細分市場機會分析

市場動態與展望

• 市場規模
• 市場動態
  • 促進因素和機遇
  • 限制與挑戰
• 波特分析

關鍵市場考察

• 關鍵成功因素
• 競爭程度
• 關鍵投資機會
• 市場生態系統
• 市場吸引力指數（2025）
• PESTEL 分析
• 總體經濟指標
• 價值鏈分析
• 定價分析
• 案例研究
• 監管環境

全球血小板凝集裝置市場規模（按產品和複合年成長率分類）（2026-2033 年）

• 系統
• 試劑
• 耗材和配件

全球血小板凝集裝置市場規模（按應用及複合年成長率分類）（2026-2033 年）

• 臨床應用
• 研究用途

全球血小板凝集裝置市場規模（按最終用戶和複合年成長率分類）（2026-2033 年）

• 醫院和診所
• 診斷實驗室
• 研究和學術機構
• 其他

全球血小板凝集裝置市場規模及複合年成長率（2026-2033）

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲地區
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 亞太其他地區
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地區
• 中東和非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東和非洲地區

競爭資訊

• 前五大公司對比
• 主要企業的市場定位（2025 年）
• 主要市場參與者所採取的策略
• 近期市場趨勢
• 公司市佔率分析（2025 年）
• 主要企業公司簡介
  • 公司詳情
  • 產品系列分析
  • 依業務板塊進行公司股票分析
  • 2023-2025年營收年比比較

主要企業簡介

• F. Hoffmann-La Roche Ltd.（Switzerland）
• Siemens Healthineers AG（Germany）
• Haemonetics Corporation（USA）
• Sysmex Corporation（Japan）
• Helena Laboratories Corporation（USA）
• Chrono-Log Corporation（USA）
• Drucker Diagnostics（USA）
• Werfen（Spain）
• Aggredyne, Inc.（USA）
• Sentinel CH. SpA（Italy）
• Tem Group（Germany）
• LSI Medience Corporation（Japan）
• Matis Medical Inc.（USA）
• Hart Biologicals（UK）

結論與建議

Global Platelet Aggregation Devices Market size was valued at USD 590.51 Million in 2024 and is poised to grow from USD 630.66 Million in 2025 to USD 1067.5 Million by 2033, growing at a CAGR of 6.8% during the forecast period (2026-2033).

The global market for platelet aggregation devices is witnessing substantial growth due to various driving factors. A rising prevalence of targeted diseases, alongside an expanding elderly population, significantly contributes to this upward trend. Innovations in platelet aggregometry, crucial for analyzing platelet function and related disorders, are also enhancing market dynamics. Moreover, increased partnerships between industry leaders and academic institutions, coupled with a surge in clinical studies, is spurring innovation within the market. However, challenges remain, including procedural limitations in healthcare, unfavorable reforms within the U.S. healthcare system, and a lack of adequately trained professionals, which could hinder potential market advancement. Overall, the market presents a dynamic landscape filled with both opportunities and challenges.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Platelet Aggregation Devices market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Platelet Aggregation Devices Market Segments Analysis

Global Platelet Aggregation Devices Market is segmented by Product, Application, End User and region. Based on Product, the market is segmented into Systems, Reagents and Consumables and Accessories. Based on Application, the market is segmented into Clinical Applications and Research Applications. Based on End User, the market is segmented into Hospitals and Clinics, Diagnostic Laboratories, Research and Academic Institutes and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Platelet Aggregation Devices Market

The growing global demand for platelet aggregation devices presents significant growth prospects for stakeholders in this market. This surge in demand is largely driven by the increasing prevalence of chronic and bleeding disorders around the world. As these medical conditions become more widespread, there is a corresponding need for sophisticated diagnostic and monitoring tools. Platelet aggregation devices are crucial in this context, as they facilitate the assessment of platelet function and are essential for the diagnosis and management of various coagulation-related disorders. Their importance in healthcare is expected to propel market expansion in the foreseeable future.

Restraints in the Global Platelet Aggregation Devices Market

The global platelet aggregation devices market encounters significant challenges that hinder its expansion. One primary obstacle is the elevated cost of these devices, which presents a financial burden for healthcare organizations and facilities, often restricting their capability to invest in such advanced diagnostic technologies. In addition, the lack of adequately trained personnel to operate and maintain these devices exacerbates the situation, resulting in underutilization and inefficiencies. This combination of high expenses and a shortfall of skilled expertise hampers the market's growth potential, ultimately limiting access to essential diagnostic capabilities for patients and healthcare providers alike.

Market Trends of the Global Platelet Aggregation Devices Market

The Global Platelet Aggregation Devices market is experiencing robust growth fueled by the increasing prevalence of hemostasis disorders worldwide. The rising incidence of conditions affecting blood clotting processes has heightened the need for effective diagnostic tools, particularly those that assess platelet function and identify coagulation abnormalities. As healthcare professionals recognize the critical importance of platelet aggregation testing in managing these disorders, the demand for innovative and reliable devices is surging. This trend is also supported by advancements in technology and growing awareness among clinicians regarding the benefits of accurate hemostasis evaluation, positioning the market for sustained expansion in the coming years.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2025
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Case Studies
• Regulatory Landscape

Global Platelet Aggregation Devices Market Size by Product & CAGR (2026-2033)

• Market Overview
• Systems
• Reagents
• Consumables and Accessories

Global Platelet Aggregation Devices Market Size by Application & CAGR (2026-2033)

• Market Overview
• Clinical Applications
• Research Applications

Global Platelet Aggregation Devices Market Size by End User & CAGR (2026-2033)

• Market Overview
• Hospitals and Clinics
• Diagnostic Laboratories
• Research and Academic Institutes
• Others

Global Platelet Aggregation Devices Market Size & CAGR (2026-2033)

• North America (Product, Application, End User)
  • US
  • Canada
• Europe (Product, Application, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product, Application, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product, Application, End User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product, Application, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• F. Hoffmann-La Roche Ltd. (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Siemens Healthineers AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Haemonetics Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sysmex Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Helena Laboratories Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Chrono-Log Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Drucker Diagnostics (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Werfen (Spain)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Aggredyne, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sentinel CH. SpA (Italy)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Tem Group (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• LSI Medience Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Matis Medical Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Hart Biologicals (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations